(1S,2S)-Bortezomib, CAS [[1132709-14-8]]

Produktübersicht

• Artikelname: (1S,2S)-Bortezomib, CAS [[1132709-14-8]]
• Artikelnummer: MCE-HY-135396
• Hersteller Artikelnummer: HY-135396
• Alternativnummer: MCE-HY-135396-10MMX1ML,MCE-HY-135396-1MG,MCE-HY-135396-10MG,MCE-HY-135396-5MG,MCE-HY-135396-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

(1S,2S)-Bortezomib is an enantiomer of Bortezomib. Bortezomib is a cell-permeable, reversible, and selective proteasome inhibitor, and potently inhibits 20S proteasome (Ki of 0.6 nM) by targeting a threonine residue. Bortezomib disrupts the cell cycle, induces apoptosis, and inhibits NF-kappaB. Bortezomib is an anti-cancer agent and the first therapeutic proteasome inhibitor to be used in humans[1][2][3].

Produkteigenschaften

• Molekulargewicht: 384.24
• Reinheit: 97
• CAS Nummer: [1132709-14-8]
• Formel: C19H25BN4O4
• Target-Kategorie: Apoptosis,Proteasome

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound